Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: 90Yttrium Colloid for the Treatment of Cystic Sellar/Parasellar Tumors [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Yttrium-90 colloid for cystic tumors of the sellar/parasellar region, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Yttrium-90 Colloid (yttrium-90 colloid)

Snippet

Sponsor: David Clarke | Conditions: Cystic Tumors of the Sellar/Parasellar Region | Phase 3 | Status: RECRUITING